nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—Haemoglobin—Carmustine—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Quinidine barbiturate—Urticaria—Teniposide—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Quinidine barbiturate—Oliguria—Methotrexate—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Carmustine—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Teniposide—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Teniposide—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Quinidine barbiturate—Erythema—Bleomycin—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Quinidine barbiturate—Hallucination—Carmustine—lymphatic system cancer	0.00204	0.00204	CcSEcCtD
Quinidine barbiturate—Sweating—Mitoxantrone—lymphatic system cancer	0.00204	0.00204	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Fludarabine—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Fludarabine—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Quinidine barbiturate—Visual impairment—Carmustine—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Quinidine barbiturate—Hallucination—Vincristine—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Quinidine barbiturate—Pain—Fludarabine—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Quinidine barbiturate—Constipation—Fludarabine—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Quinidine barbiturate—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Vincristine—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Quinidine barbiturate—Respiratory failure—Methotrexate—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Vincristine—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Quinidine barbiturate—Eye disorder—Carmustine—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Teniposide—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Quinidine barbiturate—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Quinidine barbiturate—Flushing—Carmustine—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Quinidine barbiturate—Asthenia—Teniposide—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Quinidine barbiturate—Pruritus—Teniposide—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Quinidine barbiturate—Leukopenia—Bleomycin—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Quinidine barbiturate—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Vincristine—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Fludarabine—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Quinidine barbiturate—Mental disorder—Carmustine—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Quinidine barbiturate—Erythema—Carmustine—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Quinidine barbiturate—Malnutrition—Carmustine—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Quinidine barbiturate—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Teniposide—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Quinidine barbiturate—Myalgia—Bleomycin—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Quinidine barbiturate—Chest pain—Bleomycin—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Quinidine barbiturate—Coma—Methotrexate—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Quinidine barbiturate—Mental disorder—Vincristine—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Quinidine barbiturate—Chills—Mitoxantrone—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Quinidine barbiturate—Ecchymosis—Methotrexate—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Quinidine barbiturate—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Quinidine barbiturate—Confusional state—Bleomycin—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Quinidine barbiturate—Vision blurred—Carmustine—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Quinidine barbiturate—Tremor—Carmustine—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Quinidine barbiturate—Oedema—Bleomycin—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Quinidine barbiturate—Erythema—Mitoxantrone—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Quinidine barbiturate—Vomiting—Teniposide—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Quinidine barbiturate—Agitation—Carmustine—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Quinidine barbiturate—Asthenia—Fludarabine—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Quinidine barbiturate—Rash—Teniposide—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Quinidine barbiturate—Dermatitis—Teniposide—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Quinidine barbiturate—Headache—Teniposide—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Quinidine barbiturate—Pruritus—Fludarabine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Quinidine barbiturate—Leukopenia—Carmustine—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Quinidine barbiturate—Anorexia—Bleomycin—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Quinidine barbiturate—Agitation—Vincristine—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Quinidine barbiturate—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Quinidine barbiturate—Photosensitivity—Methotrexate—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Quinidine barbiturate—Hypotension—Bleomycin—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Fludarabine—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Quinidine barbiturate—Convulsion—Carmustine—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Quinidine barbiturate—Nausea—Teniposide—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Quinidine barbiturate—Vertigo—Vincristine—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Quinidine barbiturate—Leukopenia—Vincristine—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Quinidine barbiturate—Myalgia—Carmustine—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Quinidine barbiturate—Chest pain—Carmustine—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Quinidine barbiturate—Anxiety—Carmustine—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Bleomycin—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Quinidine barbiturate—Renal failure acute—Methotrexate—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Quinidine barbiturate—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Quinidine barbiturate—Convulsion—Vincristine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Quinidine barbiturate—Confusional state—Carmustine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Quinidine barbiturate—Oedema—Carmustine—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Quinidine barbiturate—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Bleomycin—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Quinidine barbiturate—Myalgia—Vincristine—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Quinidine barbiturate—Visual disturbance—Methotrexate—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Quinidine barbiturate—Vomiting—Fludarabine—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Quinidine barbiturate—Convulsion—Mitoxantrone—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Quinidine barbiturate—Rash—Fludarabine—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Quinidine barbiturate—Dermatitis—Fludarabine—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Quinidine barbiturate—Pain—Bleomycin—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Quinidine barbiturate—Headache—Fludarabine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Quinidine barbiturate—Tachycardia—Carmustine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Quinidine barbiturate—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Quinidine barbiturate—Chest pain—Mitoxantrone—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Quinidine barbiturate—Myalgia—Mitoxantrone—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Quinidine barbiturate—Anxiety—Mitoxantrone—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Quinidine barbiturate—Lethargy—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Quinidine barbiturate—Oedema—Vincristine—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Quinidine barbiturate—Anorexia—Carmustine—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Quinidine barbiturate—Confusional state—Mitoxantrone—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Vincristine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Quinidine barbiturate—Hypotension—Carmustine—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Quinidine barbiturate—Oedema—Mitoxantrone—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Quinidine barbiturate—Nausea—Fludarabine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Quinidine barbiturate—Shock—Mitoxantrone—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Quinidine barbiturate—Urticaria—Bleomycin—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Quinidine barbiturate—Anorexia—Vincristine—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Quinidine barbiturate—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Bleomycin—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Quinidine barbiturate—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Quinidine barbiturate—Irritability—Methotrexate—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Quinidine barbiturate—Mood swings—Methotrexate—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Quinidine barbiturate—Hypotension—Vincristine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Carmustine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Quinidine barbiturate—Somnolence—Carmustine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Quinidine barbiturate—Anorexia—Mitoxantrone—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Quinidine barbiturate—Ataxia—Methotrexate—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Quinidine barbiturate—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Carmustine—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Quinidine barbiturate—Hypotension—Mitoxantrone—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Quinidine barbiturate—Pain—Carmustine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Quinidine barbiturate—Constipation—Carmustine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Quinidine barbiturate—Breast disorder—Methotrexate—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Quinidine barbiturate—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Vincristine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Quinidine barbiturate—Somnolence—Mitoxantrone—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Carmustine—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Quinidine barbiturate—Asthenia—Bleomycin—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Quinidine barbiturate—Pain—Vincristine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Quinidine barbiturate—Constipation—Vincristine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Quinidine barbiturate—Asthma—Methotrexate—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Quinidine barbiturate—Pruritus—Bleomycin—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Quinidine barbiturate—Pain—Mitoxantrone—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Quinidine barbiturate—Constipation—Mitoxantrone—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Carmustine—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Carmustine—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Quinidine barbiturate—Neutropenia—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Vincristine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Vincristine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Quinidine barbiturate—Urticaria—Mitoxantrone—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Carmustine—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Quinidine barbiturate—Vomiting—Bleomycin—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Quinidine barbiturate—Drowsiness—Methotrexate—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Quinidine barbiturate—Rash—Bleomycin—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Quinidine barbiturate—Dermatitis—Bleomycin—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Quinidine barbiturate—Asthenia—Carmustine—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Quinidine barbiturate—Renal failure—Methotrexate—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Vincristine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Quinidine barbiturate—Sweating—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000999	0.000999	CcSEcCtD
Quinidine barbiturate—Asthenia—Vincristine—lymphatic system cancer	0.000999	0.000999	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Carmustine—lymphatic system cancer	0.000998	0.000998	CcSEcCtD
Quinidine barbiturate—Nausea—Bleomycin—lymphatic system cancer	0.000993	0.000993	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000989	0.000989	CcSEcCtD
Quinidine barbiturate—Asthenia—Mitoxantrone—lymphatic system cancer	0.000973	0.000973	CcSEcCtD
Quinidine barbiturate—Dizziness—Carmustine—lymphatic system cancer	0.000965	0.000965	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Methotrexate—lymphatic system cancer	0.000956	0.000956	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Vincristine—lymphatic system cancer	0.000953	0.000953	CcSEcCtD
Quinidine barbiturate—Hepatitis—Methotrexate—lymphatic system cancer	0.000951	0.000951	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Methotrexate—lymphatic system cancer	0.000951	0.000951	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000939	0.000939	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Methotrexate—lymphatic system cancer	0.000933	0.000933	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000928	0.000928	CcSEcCtD
Quinidine barbiturate—Vomiting—Carmustine—lymphatic system cancer	0.000928	0.000928	CcSEcCtD
Quinidine barbiturate—Dizziness—Vincristine—lymphatic system cancer	0.000921	0.000921	CcSEcCtD
Quinidine barbiturate—Rash—Carmustine—lymphatic system cancer	0.00092	0.00092	CcSEcCtD
Quinidine barbiturate—Dermatitis—Carmustine—lymphatic system cancer	0.000919	0.000919	CcSEcCtD
Quinidine barbiturate—Visual impairment—Methotrexate—lymphatic system cancer	0.000917	0.000917	CcSEcCtD
Quinidine barbiturate—Headache—Carmustine—lymphatic system cancer	0.000914	0.000914	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000899	0.000899	CcSEcCtD
Quinidine barbiturate—Eye disorder—Methotrexate—lymphatic system cancer	0.000889	0.000889	CcSEcCtD
Quinidine barbiturate—Tinnitus—Methotrexate—lymphatic system cancer	0.000887	0.000887	CcSEcCtD
Quinidine barbiturate—Vomiting—Vincristine—lymphatic system cancer	0.000886	0.000886	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000883	0.000883	CcSEcCtD
Quinidine barbiturate—Rash—Vincristine—lymphatic system cancer	0.000878	0.000878	CcSEcCtD
Quinidine barbiturate—Dermatitis—Vincristine—lymphatic system cancer	0.000877	0.000877	CcSEcCtD
Quinidine barbiturate—Headache—Vincristine—lymphatic system cancer	0.000873	0.000873	CcSEcCtD
Quinidine barbiturate—Nausea—Carmustine—lymphatic system cancer	0.000867	0.000867	CcSEcCtD
Quinidine barbiturate—Vomiting—Mitoxantrone—lymphatic system cancer	0.000862	0.000862	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Methotrexate—lymphatic system cancer	0.000859	0.000859	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000857	0.000857	CcSEcCtD
Quinidine barbiturate—Rash—Mitoxantrone—lymphatic system cancer	0.000855	0.000855	CcSEcCtD
Quinidine barbiturate—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000855	0.000855	CcSEcCtD
Quinidine barbiturate—Chills—Methotrexate—lymphatic system cancer	0.000854	0.000854	CcSEcCtD
Quinidine barbiturate—Headache—Mitoxantrone—lymphatic system cancer	0.00085	0.00085	CcSEcCtD
Quinidine barbiturate—Mental disorder—Methotrexate—lymphatic system cancer	0.000833	0.000833	CcSEcCtD
Quinidine barbiturate—Erythema—Methotrexate—lymphatic system cancer	0.000828	0.000828	CcSEcCtD
Quinidine barbiturate—Malnutrition—Methotrexate—lymphatic system cancer	0.000828	0.000828	CcSEcCtD
Quinidine barbiturate—Nausea—Vincristine—lymphatic system cancer	0.000827	0.000827	CcSEcCtD
Quinidine barbiturate—Nausea—Mitoxantrone—lymphatic system cancer	0.000806	0.000806	CcSEcCtD
Quinidine barbiturate—Vision blurred—Methotrexate—lymphatic system cancer	0.00078	0.00078	CcSEcCtD
Quinidine barbiturate—Vertigo—Methotrexate—lymphatic system cancer	0.000744	0.000744	CcSEcCtD
Quinidine barbiturate—Leukopenia—Methotrexate—lymphatic system cancer	0.000741	0.000741	CcSEcCtD
Quinidine barbiturate—Convulsion—Methotrexate—lymphatic system cancer	0.000717	0.000717	CcSEcCtD
Quinidine barbiturate—Arthralgia—Methotrexate—lymphatic system cancer	0.000705	0.000705	CcSEcCtD
Quinidine barbiturate—Myalgia—Methotrexate—lymphatic system cancer	0.000705	0.000705	CcSEcCtD
Quinidine barbiturate—Chest pain—Methotrexate—lymphatic system cancer	0.000705	0.000705	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.0007	0.0007	CcSEcCtD
Quinidine barbiturate—Confusional state—Methotrexate—lymphatic system cancer	0.000681	0.000681	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000663	0.000663	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000662	0.000662	CcSEcCtD
Quinidine barbiturate—Skin disorder—Methotrexate—lymphatic system cancer	0.000656	0.000656	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000653	0.000653	CcSEcCtD
Quinidine barbiturate—Anorexia—Methotrexate—lymphatic system cancer	0.000644	0.000644	CcSEcCtD
Quinidine barbiturate—Hypotension—Methotrexate—lymphatic system cancer	0.000632	0.000632	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000616	0.000616	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Methotrexate—lymphatic system cancer	0.000603	0.000603	CcSEcCtD
Quinidine barbiturate—Somnolence—Methotrexate—lymphatic system cancer	0.000601	0.000601	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Methotrexate—lymphatic system cancer	0.000588	0.000588	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000583	0.000583	CcSEcCtD
Quinidine barbiturate—Pain—Methotrexate—lymphatic system cancer	0.000578	0.000578	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000557	0.000557	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000553	0.000553	CcSEcCtD
Quinidine barbiturate—Urticaria—Methotrexate—lymphatic system cancer	0.000537	0.000537	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Methotrexate—lymphatic system cancer	0.000534	0.000534	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Methotrexate—lymphatic system cancer	0.000534	0.000534	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000498	0.000498	CcSEcCtD
Quinidine barbiturate—Asthenia—Methotrexate—lymphatic system cancer	0.000485	0.000485	CcSEcCtD
Quinidine barbiturate—Pruritus—Methotrexate—lymphatic system cancer	0.000478	0.000478	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Methotrexate—lymphatic system cancer	0.000462	0.000462	CcSEcCtD
Quinidine barbiturate—Dizziness—Methotrexate—lymphatic system cancer	0.000447	0.000447	CcSEcCtD
Quinidine barbiturate—Vomiting—Methotrexate—lymphatic system cancer	0.00043	0.00043	CcSEcCtD
Quinidine barbiturate—Rash—Methotrexate—lymphatic system cancer	0.000426	0.000426	CcSEcCtD
Quinidine barbiturate—Dermatitis—Methotrexate—lymphatic system cancer	0.000426	0.000426	CcSEcCtD
Quinidine barbiturate—Headache—Methotrexate—lymphatic system cancer	0.000423	0.000423	CcSEcCtD
Quinidine barbiturate—Nausea—Methotrexate—lymphatic system cancer	0.000401	0.000401	CcSEcCtD
